| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.63B | 1.58B | 1.49B | 1.40B | 1.23B | 928.70M |
| Gross Profit | 1.12B | 1.27B | 1.22B | 486.20M | 428.40M | 297.90M |
| EBITDA | 263.90M | 262.10M | 241.90M | 230.90M | 214.60M | 137.70M |
| Net Income | 89.60M | 96.20M | 105.50M | 112.50M | 78.50M | 33.60M |
Balance Sheet | ||||||
| Total Assets | 2.35B | 2.11B | 1.87B | 1.79B | 1.67B | 1.62B |
| Cash, Cash Equivalents and Short-Term Investments | 20.80M | 28.90M | 126.90M | 101.70M | 83.90M | 31.70M |
| Total Debt | 668.90M | 434.20M | 296.80M | 299.40M | 296.40M | 350.00M |
| Total Liabilities | 1.21B | 943.40M | 762.10M | 742.00M | 719.70M | 730.90M |
| Stockholders Equity | 1.15B | 1.17B | 1.11B | 1.04B | 949.60M | 888.30M |
Cash Flow | ||||||
| Free Cash Flow | 58.30M | 70.40M | 86.90M | 61.20M | 117.20M | 130.30M |
| Operating Cash Flow | 193.20M | 201.70M | 193.70M | 168.00M | 194.10M | 168.40M |
| Investing Cash Flow | -300.90M | -296.20M | -120.40M | -112.90M | -75.50M | -177.80M |
| Financing Cash Flow | 98.10M | -3.00M | -46.60M | -38.00M | -65.90M | 16.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £1.25B | 28.03 | 6.07% | ― | 32.27% | ― | |
65 Neutral | £1.16B | 12.86 | 7.90% | 4.57% | 7.83% | -7.40% | |
65 Neutral | £426.34M | 18.00 | 3.57% | 4.33% | 1.31% | 10.19% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | £79.26M | 15.26 | 5.71% | 5.38% | -0.29% | -33.41% | |
60 Neutral | £383.32M | 24.43 | 7.03% | 2.14% | 15.99% | 96.05% | |
54 Neutral | £535.97M | 44.09 | 3.10% | 2.48% | 5.58% | 66.49% |
Breedon Group PLC announced that Clive Watson, a Non-executive Director and Person Discharging Managerial Responsibilities (PDMR), purchased 7,456 ordinary shares of the company at a price of £3.1692 per share on November 20, 2025. This transaction, conducted on the London Stock Exchange, aligns with the regulatory requirements of the UK Market Abuse Regulation, highlighting the director’s confidence in the company’s future prospects and potentially impacting investor sentiment positively.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £493.00 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group plc reported a resilient trading performance for the ten months ending 31 October 2025, with a 9% revenue increase compared to the same period in 2024, despite challenges such as subdued demand in residential markets in Great Britain and the US, and delays in key infrastructure projects in Great Britain and Ireland. The company remains focused on operational excellence and strategic execution, expecting to achieve profitable growth with an underlying EBITDA between £275 to £280 million. Breedon is optimistic about future opportunities, particularly with infrastructure investments in Ireland and potential growth in the US residential market, despite current economic uncertainties in the UK.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group PLC announced that Clive Watson, a Non-executive Director and Person Discharging Managerial Responsibilities (PDMR), has purchased 436 ordinary shares as part of a dividend reinvestment plan. This transaction, conducted on the London Stock Exchange, reflects the company’s adherence to the UK Market Abuse Regulation and highlights ongoing confidence in the company’s market position and future prospects.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group plc has appointed Barclays Bank PLC as a Joint Corporate Broker alongside Deutsche Numis, effective immediately. This strategic move is expected to enhance Breedon’s market presence and investor relations, potentially impacting its operations and positioning in the construction materials industry.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group PLC has announced its total voting rights in accordance with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. The company has an issued share capital consisting of 346,545,248 ordinary shares, all of which have voting rights, providing shareholders with the denominator needed to assess their interests in the company.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £393.00 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group PLC announced that its issued share capital comprises 346,538,326 ordinary shares, with none held in treasury, which defines the total number of shares with voting rights. This announcement is in line with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, providing shareholders with the necessary information to assess their interests in the company.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £397.00 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group PLC has announced its total voting rights in accordance with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. The company’s issued share capital consists of 346,531,291 ordinary shares, all of which have voting rights. This information is crucial for shareholders as it determines their obligation to notify any changes in their interest in the company.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £5.17 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group PLC announced that Abicad Holding Limited, closely associated with Non-executive Chair Amit Bhatia, acquired 300,000 ordinary shares through option agreements at a price of 392.745 pence per share. This acquisition increases Abicad’s holdings to approximately 19.00% of Breedon’s total issued share capital, with potential to rise to 19.35% if further options are exercised. This move aligns with Abicad’s ongoing strategy to increase its market share in Breedon, potentially impacting the company’s shareholder dynamics and market positioning.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £5.17 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.